- Independent in relation to the Company and its management: No
- Independent in relation to major shareholders: Yes
- Holdings in Alligator: 10,000 shares, 250,000 warrants in program TO 2022/2025 I and 600,000 warrants in program TO 2023/2026 I.
- Other current positions: Deputy Board member in A Bioscience Incentive AB and Atlas Therapeutics AB.
Malin Carlsson – born 1968, Executive Vice President & Chief Operating Officer – is a medical doctor with board certification in clinical immunology at Lund University. Malin has 20 years of research experience in immunology 12 years of experience in clinical drug development. Employed since 2020 and member of the Management Team since 2020.